These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8028004)

  • 1. Control of nucleo-cytoplasmic HLA-DRA mRNA partitioning by interaction of a retention signal with compartmentalized proteins.
    Del Pozzo G; Ciullo M; Autiero M; Guardiola J
    J Mol Biol; 1994 Jul; 240(3):193-204. PubMed ID: 8028004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
    Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
    J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A three-amino-acid-long HLA-DRbeta cytoplasmic tail is sufficient to overcome ER retention of invariant-chain p35.
    Khalil H; Brunet A; Thibodeau J
    J Cell Sci; 2005 Oct; 118(Pt 20):4679-87. PubMed ID: 16188937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A binding protein to the DNase I hypersensitive site II in HLA-DR alpha gene was identified as NF90.
    Sakamoto S; Morisawa K; Ota K; Nie J; Taniguchi T
    Biochemistry; 1999 Mar; 38(11):3355-61. PubMed ID: 10079079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y; Chamuleau ME; van de Loosdrecht AA; Tolosa E; Jorritsma T; Muris JJ; Dinnissen-van Poppel MJ; Snel SN; van de Corput L; Ossenkoppele GJ; Meijer CJ; Neefjes JJ; Marieke van Ham S
    Br J Haematol; 2009 May; 145(3):334-43. PubMed ID: 19245431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.
    Lu Y; Boss JM; Hu SX; Xu HJ; Blanck G
    J Immunol; 1996 Apr; 156(7):2495-502. PubMed ID: 8786310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitor (IK) of IFN-gamma induced HLA class II antigens expression also inhibits HLA class II constitutive expression in the human Raji B cell line.
    Vedrenne J; Assier E; Pereno R; Bouzinba-Segard H; Azzarone B; Jasmin C; Charron D; Krief P
    Oncogene; 1997 Mar; 14(12):1453-61. PubMed ID: 9136989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polarized transport of MHC class II molecules in Madin-Darby canine kidney cells is directed by a leucine-based signal in the cytoplasmic tail of the beta-chain.
    Simonsen A; Pedersen KW; Nordeng TW; von der Lippe A; Stang E; Long EO; Bakke O
    J Immunol; 1999 Sep; 163(5):2540-8. PubMed ID: 10452991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic stimulation of HIV-1 rev-dependent export of unspliced mRNA to the cytoplasm by hnRNP A1.
    Najera I; Krieg M; Karn J
    J Mol Biol; 1999 Feb; 285(5):1951-64. PubMed ID: 9925777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct role of NF-kappaB activation in Toll-like receptor-triggered HLA-DRA expression.
    Lee KW; Lee Y; Kim DS; Kwon HJ
    Eur J Immunol; 2006 May; 36(5):1254-66. PubMed ID: 16619292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiation by thyroid hormone of human IFN-gamma-induced HLA-DR expression.
    Lin HY; Martino LJ; Wilcox BD; Davis FB; Gordinier JK; Davis PJ
    J Immunol; 1998 Jul; 161(2):843-9. PubMed ID: 9670962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
    Osborne AR; Zhang H; Blanck G
    Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting signal and subcellular compartments involved in the intracellular trafficking of HLA-DMB.
    Copier J; Kleijmeer MJ; Ponnambalam S; Oorschot V; Potter P; Trowsdale J; Kelly A
    J Immunol; 1996 Aug; 157(3):1017-27. PubMed ID: 8757605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of heterogeneous nuclear ribonucleoprotein C1/C2 with a novel cis-regulatory element within p53 mRNA as a response to cytostatic drug treatment.
    Christian KJ; Lang MA; Raffalli-Mathieu F
    Mol Pharmacol; 2008 May; 73(5):1558-67. PubMed ID: 18296503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular proteins that bind to the hepatitis B virus posttranscriptional regulatory element.
    Huang ZM; Zang WQ; Yen TS
    Virology; 1996 Mar; 217(2):573-81. PubMed ID: 8610449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel DNase I hypersensitive site within the far upstream region of the human HLA-DRA gene.
    Tomassetti M; Feriotto G; Giacomini P; Giorda E; Bianchi N; Borgatti M; Finotti A; Mischiati C; Gambari R
    Int J Mol Med; 2003 Dec; 12(6):929-34. PubMed ID: 14612968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of HLA antigens from membrane-associated messenger RNA.
    Lee JS; Trowsdale J; Bodmer WF
    J Exp Med; 1980 Aug; 152(2 Pt 2):3s-10s. PubMed ID: 7411016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The regulation mechanism of HLA class II gene expression at the level of mRNA stability.
    Del Pozzo G; Guardiola J
    Immunogenetics; 1996; 44(6):453-8. PubMed ID: 8824157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.